The family of the superconducting quasiskutterudites (Ca(x)Sr(1-x))(3)Rh(4)Sn(13) features a structural quantum critical point at x(c)=0.9, around which a dome-shaped variation of the superconducting transition temperature T(c) is found. Using specific heat, we probe the normal and the superconducting states of the entire series straddling the quantum critical point. Our analysis indicates a significant lowering of the effective Debye temperature on approaching x(c), which we interpret as a result of phonon softening accompanying the structural instability. Furthermore, a remarkably large enhancement of 2Δ/k(B)T(c) and ΔC/γT(c) beyond the Bardeen-Cooper-Schrieffer values is found in the vicinity of the structural quantum critical point. The phase diagram of (Ca(x)Sr(1-x))(3)Rh(4)Sn(13) thus provides a model system to study the interplay between structural quantum criticality and strong electron-phonon coupling superconductivity.
Mitochondrial fragmentation due to fission/fusion imbalance has often been linked to mitochondrial dysfunction and apoptosis in neurodegeneration. Conventionally, it is believed that once mitochondrial morphology shifts away from its physiological tubular form, mitochondria become defective and downstream apoptotic signaling pathways are triggered. However, our study shows that beta-amyloid (Aβ) induces morphological changes in mitochondria where they become granular-shaped and are distinct from fragmented mitochondria in terms of both morphology and functions. Accumulation of mitochondrial reactive oxygen species triggers granular mitochondria formation, while mitoTEMPO (a mitochondria-targeted superoxide scavenger) restores tubular mitochondrial morphology within Aβ-treated neurons. Interestingly, modulations of mitochondria fission and fusion by genetic and pharmacological tools attenuated not only the induction of granular mitochondria, but also mitochondrial superoxide levels in Aβ−treated neurons. Our study shows a reciprocal relationship between mitochondrial dynamics and reactive oxygen species and provides a new potential therapeutic target at early stages of neurodegenerative disease pathogenesis.
LiOsO3 undergoes a continuous transition from a centrosymmetric R3c structure to a polar R3c structure at Ts = 140 K. By combining transport measurements and first-principles calculations, we find that Ts is enhanced by applied pressure, and it reaches a value of ∼250 K at ∼6.5 GPa. The enhancement is due to the fact that the polar R3c structure of LiOsO3 has a smaller volume than the centrosymmetric R3c structure. Pressure generically favors the structure with the smallest volume, and therefore further stabilizes the polar R3c structure over the R3c structure, leading to the increase in Ts.
The quasiskutterudite superconductor La 3 Co 4 Sn 13 undergoes a phase transition at T * = 152 K. By measuring the temperature dependence of heat capacity, electrical resistivity, and the superlattice reflection intensity using x rays, we explore the character of the phase transition at T * . Our lattice dynamic calculations found imaginary phonon frequencies around the M point when the high-temperature structure is used in the calculations, indicating that the structure is unstable at the zero-temperature limit. The combined experimental and computational results establish that T * is associated with a second-order structural transition with q = (0.5,0.5,0) (or the M point). Further electronic band structure calculations reveal Fermi surface sheets with low-curvature segments, which allow us to draw qualitative comparison with both Sr 3 Ir 4 Sn 13 and Sr 3 Rh 4 Sn 13 in which similar physics has been discussed recently.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.